tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

SXTP Stock Latest News

60 Degrees Pharmaceuticals, Inc. Announces Closing of $4 Million Private Placement Priced At-the-Market Under Nasdaq Rules
Press Releases60 Degrees Pharmaceuticals, Inc. Announces Closing of $4 Million Private Placement Priced At-the-Market Under Nasdaq Rules
14d ago
SXTP
60 Degrees Pharmaceuticals to sell 2.9M shares at $1.38 in private placement
PremiumThe Fly
60 Degrees Pharmaceuticals to sell 2.9M shares at $1.38 in private placement
16d ago
SXTP
60 Degrees Pharmaceuticals, Inc. Announces $4 Million Private Placement Priced At-the-Market Under Nasdaq Rules
PremiumPress Releases
60 Degrees Pharmaceuticals, Inc. Announces $4 Million Private Placement Priced At-the-Market Under Nasdaq Rules
16d ago
SXTP
60 Degrees Pharmaceuticals regains compliance with Nasdaq listing requirements
PremiumThe Fly
60 Degrees Pharmaceuticals regains compliance with Nasdaq listing requirements
23d ago
SXTP
60 Degrees Pharmaceuticals, Inc. Regains Compliance with Nasdaq Listing Requirements
PremiumPress Releases
60 Degrees Pharmaceuticals, Inc. Regains Compliance with Nasdaq Listing Requirements
23d ago
SXTP
60 Degrees Pharmaceuticals Announces Second Quarter 2024 Results
PremiumPress Releases60 Degrees Pharmaceuticals Announces Second Quarter 2024 Results
1M ago
SXTP
60 Degrees Pharma Provides University of Kentucky with Right of Reference to ARAKODA® NDA in Support of SJ733 Phase IIb Study
Premium
Press Releases
60 Degrees Pharma Provides University of Kentucky with Right of Reference to ARAKODA® NDA in Support of SJ733 Phase IIb Study
1M ago
SXTP
60 Degrees granted University of Kentucky right to reference NDA for ARAKODA
Premium
The Fly
60 Degrees granted University of Kentucky right to reference NDA for ARAKODA
1M ago
SXTP
60 Degrees Pharmaceuticals Inc trading halted, news pending
PremiumThe Fly
60 Degrees Pharmaceuticals Inc trading halted, news pending
1M ago
SXTP
60 Degrees Pharmaceuticals, Inc. Announces 1:12 Reverse Stock Split
PremiumPress Releases
60 Degrees Pharmaceuticals, Inc. Announces 1:12 Reverse Stock Split
1M ago
SXTP
60 Degrees Pharmaceuticals announces 1-for-12 reverse stock split
PremiumThe Fly
60 Degrees Pharmaceuticals announces 1-for-12 reverse stock split
1M ago
SXTP
60 Degrees Pharmaceuticals Awarded Contract with U.S. Army for ARAKODA® Supply Chain Upgrade Support
PremiumPress Releases
60 Degrees Pharmaceuticals Awarded Contract with U.S. Army for ARAKODA® Supply Chain Upgrade Support
2M ago
SXTP
60 Degrees Pharmaceuticals awarded contract with U.S. Army for ARAKODA
PremiumThe Fly60 Degrees Pharmaceuticals awarded contract with U.S. Army for ARAKODA
2M ago
SXTP
60 Degrees Pharmaceuticals Signs Clinical Trial Agreements With All Planned Trial Sites for Tafenoquine Babesiosis Study
Premium
Press Releases
60 Degrees Pharmaceuticals Signs Clinical Trial Agreements With All Planned Trial Sites for Tafenoquine Babesiosis Study
2M ago
SXTP
60 Degrees signs trial agreements with planned sites for Tafenoquine
Premium
The Fly
60 Degrees signs trial agreements with planned sites for Tafenoquine
2M ago
SXTP
60 Degrees Pharmaceuticals files $15M mixed securities shelf
PremiumThe Fly
60 Degrees Pharmaceuticals files $15M mixed securities shelf
2M ago
SXTP
60 Degrees Pharmaceuticals’ study of tafenoquine in babesiosis approved
PremiumThe Fly
60 Degrees Pharmaceuticals’ study of tafenoquine in babesiosis approved
2M ago
SXTP
60 Degrees Pharma Announces IRB Approval of Clinical Study of Tafenoquine for Treatment of Babesiosis in Immunocompromised Patients with Persistent Babesia microti Despite Prior Treatment
PremiumPress Releases
60 Degrees Pharma Announces IRB Approval of Clinical Study of Tafenoquine for Treatment of Babesiosis in Immunocompromised Patients with Persistent Babesia microti Despite Prior Treatment
2M ago
SXTP
60 Degrees announces first patient enrolled in clinical trial of Tafenoquine
PremiumThe Fly
60 Degrees announces first patient enrolled in clinical trial of Tafenoquine
3M ago
SXTP
First Patient Enrolled in 60 Degrees Pharmaceuticals Clinical Trial of Tafenoquine for Babesiosis at Tufts Medical Center; First and Only Study of Its Kind
PremiumPress ReleasesFirst Patient Enrolled in 60 Degrees Pharmaceuticals Clinical Trial of Tafenoquine for Babesiosis at Tufts Medical Center; First and Only Study of Its Kind
3M ago
SXTP
60 Degrees Pharmaceuticals receives FDA ODD for Tafenoquine
Premium
The Fly
60 Degrees Pharmaceuticals receives FDA ODD for Tafenoquine
3M ago
SXTP
60 Degrees Pharmaceuticals Receives FDA Orphan Drug Designation for Tafenoquine for Treatment of Patients with Acute Babesiosis
Premium
Press Releases
60 Degrees Pharmaceuticals Receives FDA Orphan Drug Designation for Tafenoquine for Treatment of Patients with Acute Babesiosis
3M ago
SXTP

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >